Description

Cagrilintide (Long‑acting Amylin Analogue)

Description

• Cagrilintide is a synthetic, long‑acting amylin analogue that mimics the hormone amylin to reduce appetite, slow gastric emptying, and support weight loss.
• Investigational peptide studied alone and in combination with GLP‑1 therapies for obesity and metabolic improvement.

Key benefits (research findings)

• Reduces appetite and caloric intake by acting on central satiety pathways.
• Slows gastric emptying to promote fullness and reduce meal size.
• When combined with GLP‑1 agonists in trials, shows enhanced weight‑loss efficacy versus single agents.
• May improve metabolic parameters (e.g., body weight, glycemic markers) in clinical studies.

Who it’s for

• Adults with overweight or obesity enrolled in clinical trials or receiving treatment under approved protocols.
• Should be used under medical supervision; not intended for unsupervised self‑administration.

Suggested use

• Administered by subcutaneous injection per clinical trial or prescribing protocol; dosing regimens and titration vary by study.
• Often studied in fixed‑dose regimens or co‑administration with GLP‑1 receptor agonists—follow clinician or protocol instructions.

Safety and storage

• Adverse effects reported in studies include nausea, vomiting, constipation, injection‑site reactions, and transient gastrointestinal symptoms; monitor clinically.
• Contraindications and precautions vary by individual health status—consult a healthcare professional before use.
• Store and handle per manufacturer or protocol guidance (typically refrigerated and protected from light); maintain sterility for injectable formulations.

Quick facts

• Mechanism: amylin receptor agonism (appetite suppression, delayed gastric emptying).
• Status: investigational for obesity/metabolic indications; regulatory approval and availability vary by region.
• Often evaluated in combination with GLP‑1 therapies for additive weight‑loss effects.

Research Use Only Disclaimer

Products sold by SoCo Peptides are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, veterinary use, household use, cosmetic use, or therapeutic application. They are not drugs, foods, or dietary supplements and have not been evaluated or approved by the FDA.

By purchasing from this website, the customer represents that they are a qualified researcher or laboratory professional and understand the risks associated with handling research materials.

All products must be handled by trained professionals in appropriate research facilities and in accordance with all applicable laws and regulations.

SoCo Peptides makes no guarantees or claims regarding safety, effectiveness, or medical benefit.